Papua New Guinea Institute of Medical Research   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Goroka Papua New Guinea (1968)

Organization Overview

First Clinical Trial
2000
NCT00322907
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Papua New Guinea Institution for Medical Research

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Bacteremia (Phase 3)

Communicable Diseases (Phase 4)

Elephantiasis (Phase 2)

Elephantiasis, Filarial (Phase 2)

Filariasis (Phase 2)

Infections (Phase 4)

Malaria (Phase 4)

Meningitis (Phase 3)

Otitis Media (Phase 3)

Pneumonia (Phase 3)

Sexually Transmitted Diseases (Phase 3)

Yaws (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 21